National Cancer Institute

FY 2017 Research Funding by Research Topic

Cancer Type Funded Amount
Agent Orange/Dioxin Related $295,552
Aging $56,326,754
Alcoholism Research $331,677
Arctic $1,400,837
Arthritis $510,171
Ataxia Telangiectasia $1,708,530
Autoimmune Diseases $8,128,980
Basic Behavioral and Social Science $62,031,760
Behavioral and Social Science $228,905,461
Biochemical Epidemiology $160,964,695
Bioengineering $153,597,647
Bone Marrow Transplantation $39,362,912
Cancer $5,636,393,224
Cancer Survivorship $184,585,997
Cervical Cancer Education $5,604,902
Chemoprevention $96,073,986
Chemotherapy $317,746,569
Childhood Cancers $220,273,687
Chronic Myeloproliferative Disorders $16,629,705
Contraception and Reproduction Research $3,536,204
Depression Research $14,084,264
Diabetes $14,412,596
Digestive Diseases $532,523,882
Down Syndrome $1,500,144
Gene Therapy $35,689,813
Gene Therapy Clinical Trials $6,605,745
Genetic Testing $25,304,806
Herpes - Genital $918,314
Herpes - Other $50,074,340
Inflammatory Bowel Disease $3,102,212
Interferon $4,542,084
Metastasis $427,988,852
Neurofibromatosis $8,222,655
Nuclear Magnetic Resonance Imaging (NMR) $90,308,660
Nursing Oncology $17,458,887
Organ Transplantation Research $46,471,891
Pesticides $2,895,341
Sleep Disorders $11,085,672
Smoking Behavior $73,245,201
Surgery $66,954,492
Taxol $21,807,981
Tuberous Sclerosis $1,354,726